Recent advances in the characterization of amorphous pharmaceuticals by X-ray diffractometry

Area of Science:

• Pharmaceutical Science
• Materials Science
• Analytical Chemistry

Background:

• Poorly water-soluble drugs often exhibit low oral bioavailability.
• The amorphous solid state can significantly enhance drug solubility and absorption.
• Physical instability and crystallization propensity are key challenges for amorphous drugs.

Purpose of the Study:

• To highlight the utility of advanced X-ray scattering techniques for characterizing amorphous pharmaceutical systems.
• To discuss the role of preparation methods and sample history on amorphous phase properties.
• To emphasize the importance of detecting and quantifying crystallization in amorphous drugs.

Main Methods:

• Coupling X-ray total scattering with the pair distribution function (PDF) analysis.
• Utilizing advanced X-ray diffraction (XRD) instrumentation for enhanced sensitivity.
• Leveraging the International Centre for Diffraction Data (ICDD) database for amorphous materials.

Main Results:

• X-ray total scattering and PDF analysis provide structural insights into amorphous and nanocrystalline materials.
• These methods enable fingerprinting, quantification, and modeling of amorphous pharmaceutical systems.
• Recent instrumental advancements improve the detection and quantification of crystallization in complex matrices.

Conclusions:

• Advanced X-ray scattering techniques are crucial for understanding and controlling amorphous drug formulations.
• Accurate characterization of amorphous states is essential for ensuring drug stability and efficacy.
• The ICDD database serves as a valuable resource for quality assessment of amorphous materials.